These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 33614477)

  • 61. Hepatic Arterial Infusion Chemotherapy Followed by Lipiodol Infusion for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Single-Center Experience.
    Chen KT; Tsai KF; Leung HWC; Chan ALF; Wang SY; Liang HL; Tang SY; Chou CK; Chen HY; Chan SH; Li MF
    Medicina (Kaunas); 2021 Jul; 57(8):. PubMed ID: 34440985
    [No Abstract]   [Full Text] [Related]  

  • 62. Hepatitis B virus reactivation and efficacy of prophylaxis with lamivudine in patients undergoing allogeneic stem cell transplantation.
    Giaccone L; Festuccia M; Marengo A; Resta I; Sorasio R; Pittaluga F; Fiore F; Boccadoro M; Rizzetto M; Bruno B; Marzano A
    Biol Blood Marrow Transplant; 2010 Jun; 16(6):809-17. PubMed ID: 20060484
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Hepatitis B virus reactivation in patients with hepatocellular carcinoma undergoing anti-cancer therapy.
    Jang JW
    World J Gastroenterol; 2014 Jun; 20(24):7675-85. PubMed ID: 24976705
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Hepatic Arterial Infusion Chemotherapy as a Timing Strategy for Conversion Surgery to Treat Hepatocellular Carcinoma: A Single-Center Real-World Study.
    Wang J; Zheng Z; Wu T; Li W; Wang J; Pan Y; Peng W; Hu D; Hou J; Xu L; Zhang Y; Chen M; Zhang R; Zhou Z
    J Hepatocell Carcinoma; 2022; 9():999-1010. PubMed ID: 36132426
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Hepatitis B virus reactivation in B-cell lymphoma patients treated with rituximab: analysis from the Asia Lymphoma Study Group.
    Kim SJ; Hsu C; Song YQ; Tay K; Hong XN; Cao J; Kim JS; Eom HS; Lee JH; Zhu J; Chang KM; Reksodiputro AH; Tan D; Goh YT; Lee J; Intragumtornchai T; Chng WJ; Cheng AL; Lim ST; Suh C; Kwong YL; Kim WS
    Eur J Cancer; 2013 Nov; 49(16):3486-96. PubMed ID: 23910494
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Hepatitis B virus reactivation in HBsAg-positive patients with rheumatic diseases undergoing anti-tumor necrosis factor therapy or DMARDs.
    Lee YH; Bae SC; Song GG
    Int J Rheum Dis; 2013 Oct; 16(5):527-31. PubMed ID: 24164839
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effects of transarterial chemoembolization combined with antiviral therapy on HBV reactivation and liver function in HBV-related hepatocellular carcinoma patients with HBV-DNA negative.
    Wang K; Jiang G; Jia Z; Zhu X; Ni C
    Medicine (Baltimore); 2018 Jun; 97(22):e10940. PubMed ID: 29851833
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Transarterial chemoembolization with hepatic arterial infusion chemotherapy plus S-1 for hepatocellular carcinoma.
    Guo JH; Liu SX; Gao S; Kou FX; Zhang X; Wu D; Li XT; Chen H; Wang XD; Liu P; Zhang PJ; Xu HF; Cao G; Zhu LZ; Yang RJ; Zhu X
    World J Gastroenterol; 2020 Jul; 26(27):3975-3988. PubMed ID: 32774071
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Hepatitis B Virus Screening and Real Life Data in Patients with Solid Tumor Receiving Chemotherapy.
    Fidan S; Fidan E; Alandağ C; Erkut M; Cosar AM
    Arch Iran Med; 2020 Dec; 23(12):835-841. PubMed ID: 33356341
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effects of TACE and preventive antiviral therapy on HBV reactivation and subsequent hepatitis in hepatocellular carcinoma: a meta-analysis.
    Zhang SS; Liu JX; Zhu J; Xiao MB; Lu CH; Ni RZ; Qu LS
    Jpn J Clin Oncol; 2019 Jul; 49(7):646-655. PubMed ID: 30968933
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Hepatitis B virus reactivation and hepatitis in gastrointestinal cancer patients after chemotherapy.
    Yang Y; Du Y; Luo WX; Li C; Chen Y; Cheng K; Ding J; Zhou Y; Ge J; Yang X; Liu JY
    Cancer Chemother Pharmacol; 2015 Apr; 75(4):783-90. PubMed ID: 25687988
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Hepatitis B virus reactivation in hepatitis B surface antigen seropositive patients with metastatic non-small cell lung cancer receiving cytotoxic chemotherapy: the efficacy of preemptive lamivudine and identification of risk factors.
    Lin GN; Peng JW; Xiao JJ; Liu DY; Xia ZJ
    Med Oncol; 2014 Aug; 31(8):119. PubMed ID: 25023055
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Evaluation of Hepatitis B screening and reactivation in patients receiving rituximab containing chemotherapy: A single-centre study.
    Bozkurt I; Ozturk Cerik H; Kir S; Ustaoglu M; Turgut M; Esen S
    Int J Clin Pract; 2021 Oct; 75(10):e14685. PubMed ID: 34331726
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Determining Whether Prophylactic Antiviral Treatment Is Necessary in HBsAg-Negative/HBcAb-Positive Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation.
    Zhang A; Wu Y; Tan Y; Shi J; Zhao Y; Hu Y; Yu J; Zheng W; Lai X; Zhang M; Zhu Y; Ye Y; Huang Y; Fu S; Huang H; Luo Y
    Biol Blood Marrow Transplant; 2020 May; 26(5):956-964. PubMed ID: 31962163
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Impact of Hepatitis B Core Antibody Seropositivity on the Outcome of Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma.
    Varma A; Biritxinaga L; Saliba RM; Stich M; Jauch SF; Afrough A; Honhar M; Popat UR; Shafi MA; Shah N; Bashir Q; Dinh Y; Hosing C; Champlin RE; Qazilbash MH
    Biol Blood Marrow Transplant; 2017 Apr; 23(4):581-587. PubMed ID: 28063964
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Hepatitis B virus reactivation in hepatocellular carcinoma patients undergoing transcatheter arterial chemoembolization therapy.
    Peng JW; Lin GN; Xiao JJ; Jiang XM
    Asia Pac J Clin Oncol; 2012 Dec; 8(4):356-61. PubMed ID: 22897940
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Comprehensive outcomes of on- and off-antiviral prophylaxis in hepatitis B patients undergoing cancer chemotherapy: A competing risks analysis.
    An J; Shim JH; Kim SO; Choi J; Kim SW; Lee D; Kim KM; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
    J Med Virol; 2016 Sep; 88(9):1576-86. PubMed ID: 26945543
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Analysis of the prophylactic effect of nucleosides against reactivation of HBV in HBsAg-positive patients with non-hepatic tumors after chemotherapy].
    Zhang HY; Liu ZG; Zhang Z; Gong HY
    Zhonghua Zhong Liu Za Zhi; 2010 Jun; 32(6):459-62. PubMed ID: 20819491
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effect of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in lymphoma: a meta-analysis of published clinical trials and a decision tree addressing prolonged prophylaxis and maintenance.
    Ziakas PD; Karsaliakos P; Mylonakis E
    Haematologica; 2009 Jul; 94(7):998-1005. PubMed ID: 19454492
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Risk and prophylaxis strategy of hepatitis B virus reactivation in patients with lymphoma undergoing chemotherapy with or without rituximab.
    Pei SN; Chen CH
    Leuk Lymphoma; 2015 Jun; 56(6):1611-8. PubMed ID: 25248874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.